BeStock  
Stocks › Biotechnology › AGIO

Agios Pharmaceuticals AGIO

US equityMarket cap rank #2826Biotechnology
$31.25 −$0.55 (-1.73%)
Pre-market · Oct 6, 4:10 am ET · After hours $31.25 0.00%
Open$31.65
Prev close$31.80
Day range$30.78 – $31.76
Volume808.7K
Market cap$1.87B
P/E (TTM)–
Dividend yield–

AGIO Stock News

Headlines matching Agios Pharmaceuticals or the AGIO ticker, most recent first.

  • BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $50Market news · 21 Sep 2026
  • TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy RatingMarket news · 4 Aug 2026
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy RatingMarket news · 11 Aug 2026
  • A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $41 to $54Market news · 8 Jul 2026
  • BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $46Market news · 7 Jul 2026
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39Market news · 31 Jul 2026
  • A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $39 to $55Market news · 31 Jul 2026
  • BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $46Market news · 22 Jul 2026
  • H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $52Market news · 22 Jul 2026
  • H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $54Market news · 13 Jul 2026
  • H.C. Wainwright Remains a Buy on Agios Pharma (AGIO)TipRanks · 13 Jul 2026
  • Goldman Sachs Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Raises Target Price to $32Market news · 2 Jun 2026
  • H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $50Market news · 2 Jun 2026
  • A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $36 to $54Market news · 16 Jun 2026
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $36Market news · 15 Jun 2026

Discussion

No comments yet — be the first to weigh in on AGIO.

Leave a comment

Scroll to Top